Cited by 502Cardiac electrophysiology and arrhythmiasCardiomyopathy and Myosin StudiesCardiac pacing and defibrillation studies

Restoration of Contractile Function in Isolated Cardiomyocytes From Failing Human Hearts by Gene Transfer of SERCA2a

Open access
Federica del Monte, Harding, Sian E., Schmidt, Ulrich, Matsui, Takashi, Kang, Zhao Bin, Dec, G. William, Gwathmey, Judith K., Rosenzweig, Anthony +1 more·1999·Circulation

Abstract

Background —Failing human myocardium is characterized by abnormal relaxation, a deficient sarcoplasmic reticulum (SR) Ca 2+ uptake, and a negative frequency response, which have all been related to a deficiency in the SR Ca 2+ ATPase (SERCA2a) pump. Methods and Results —To test the hypothesis that an increase in SERCA2a could improve contractile function in cardiomyocytes, we overexpressed SERCA2a in human ventricular myocytes from 10 patients with end-stage heart failure and examined intracellular Ca 2+ handling and contractile function. Overexpression of SERCA2a resulted in an increase in both protein expression and pump activity and induced a faster contraction velocity (26.7±6.7% versus 16.6±2.7% shortening per second, P <0.005) and enhanced relaxation velocity (32.0±10.1% versus 15.1±2.4%, P <0.005). Diastolic Ca 2+ was decreased in failing cardiomyocytes overexpressing SERCA2a (270±26 versus 347±30 nmol/L, P <0.005), whereas systolic Ca 2+ was increased (601±38 versus 508±25 nmol/L, P <0.05). In addition, the frequency response was normalized in cardiomyocytes overexpressing SERCA2a. Conclusions —These results support the premise that gene-based therapies and targeting of specific pathways in human heart failure may offer a new modality for the treatment of this disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.100.23.2308

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
del Monte, F., Harding, S. E., Schmidt, U., Matsui, T., Kang, Z. B., Dec, G. W., Gwathmey, J. K., Rosenzweig, A., & Hajjar, R. J.
Affiliations
  • Boston University (US)
  • From the Cardiovascular Research Center (F.d.M., U.S., T.M., Z.B.K., A.R.) and the Heart Failure and Cardiac Transplantation Center (G.W.D., R.J.H.), Massachusetts General Hospital, Harvard Medical School, and Boston University School of Medicine (J.K.G.), Boston, Mass; and Imperial College, London, UK (S.E.H.).
Venue
Circulation
Published
1999-12-07
Volume
100
Issue
23
Pages
2308-2311
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2157581901
Cited by
502
References
20
Citations by year
2026: 5 · 2025: 11 · 2024: 6 · 2023: 5 · 2022: 13 · 2021: 16 · 2020: 10 · 2019: 11 · 2018: 15 · 2017: 17 · 2016: 18 · 2015: 17 · 2014: 12 · 2013: 28 · 2012: 30
FWCI
17.45
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Heart Association
  • Massachusetts General Hospital
  • British Heart Foundation
  • National Institutes of Health (5r44hl060323-03, 5r01hl049574-07)
  • National Heart, Lung, and Blood Institute (R01 HL049574-05, HL-57623, HL 50361, R01 HL049574-05S1, HL 54202, R44 HL060323-03, R44 HL060323-02A1, R01 HL049574-06S1, R01 HL049574-06, R01 HL049574-08, R01 HL049574-07, R01HL059521)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords
SERCA2a, sarcoplasmic reticulum Ca2+-ATPase, heart failure, cardiomyocytes, gene transfer, contractile function, calcium handling, diastolic calcium, relaxation velocity, contraction velocity, frequency response, gene therapy
MeSH terms
Calcium-Transporting ATPases, Calcium, Cardiomyopathy, Dilated, Cells, Cultured, Heart Failure, Humans, Myocardial Contraction, Sarcoplasmic Reticulum, Genetic Therapy, Gene Expression, Muscle Fibers, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review